AXIC A — aXichem AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK125.64m
- SEK123.38m
- SEK18.45m
Brief: Axichem Continues To Get Orders From Uriach
Brief: aXichem To Submit Additional Data On aXiphen To EFSA
Brief: Axichem Q3 Oper Loss Narrows To SEK 3.8 Mln
Brief: Axichem Receives First Order From Uriach
Brief: Axichem Updates Status For Feed Additive Application In EU For aXiphen
Brief: Axichem Sees Increased Demand For Phenylcapsaicin In H2
Brief: Axichem Signs Agreement With Uriach
Brief: aXichem Updates The Status Of Its Application For Feed Additive Approval For aXiphen In The EU
Brief: Axichem Gets Orders For Axivite From BART In Poland
Brief: Axichem Q1 Oper Loss Widens To SEK 3.8 Mln
Brief: aXichem Updates Status For Its EU Application For Feed Additive Approval
Brief: Axichem To Receive About SEK 34.7 Mln Through Rights Issue
Brief: aXichem Carries Out Rights Issue Of About SEK 50 Million
Brief: aXichem's Capsaicin Analogue, Axivite, To Be Launched In Three Products In U.S.
Brief: aXichem Enters Into Production Collaboration
Brief: Chr. Olesen Adds Axichem Ingredient Axiphen To Their Official Product Portfolio
Brief: Axichem Updates On Status Of EU Application For Feed Additive Approval
Brief: aXichem Jan-Sept Operating Loss Widens To SEK 12.3 Mln
Brief: Axichem Obtains Patent For Phenylcapsaicin For Use In The Treatment Of Idiopathic Pulmonary Fibrosis